Sikkerhedsprofilen for Mimpara hos disse patientpopulationer stemmer generelt overens med det, der ses hos patienter med kroniske nyresygdomme.
The safety profile of Mimpara in these patient populations is generally consistent with that seen in patients with Chronic Kidney Disease.